Trial Testing Immune Modulation in COVID-19 Patients Begins
National Institutes of Health
The therapeutic may prevent overactive immune systems from causing severe COVID-19-related illness
T-cells
Positive Phase 3 Data Demonstrate NSCLC Vaccine’s Efficacy
OSE Immunotherapeutics
Tedopi® safely improved overall survival and quality of life in patients with hard-to-treat non-small cell lung cancer
Latest Study Dives Deeper into T-Cell Activation and Response
La Jolla Institute for Immunology
How do T-cell receptors on the cell surface alert the nucleus far inside the cell of trouble?
New CAR T-Cell Therapy for Advanced Ovarian Cancer
City of Hope
CAR T-cell therapy targeting TAG-72 and other markers is in the first-in-human Phase 1 trial
PFAS Exposure May Suppress T-Cell Activity
Helmholtz Centre for Environmental Research (UFZ)
Study demonstrates immune-modifying effect of PFAS using multiparameter spectral flow cytometry
Key Genes for Ovarian Cancer Prognosis Identified
Imperial College London
New research highlights why some women with high-grade serous ovarian cancer respond better to treatment than others
Pan-Cancer Atlas Confirms T-Cell Heterogeneity in Tumor Microenvironment
Swathi Kodaikal, MSc
Newly discovered T-cell states and interactions may affect the success of a cancer treatment regimen
CAR NKT Cell Therapy Shows Promise Against Neuroblastoma in Phase 1 Trial
Baylor College of Medicine
Trial validates localization of NKT cells to tumor sites in humans and points to high in vivo antitumor activity
New Details on Idiopathic CD4 Lymphocytopenia Uncovered
National Institute of Allergy and Infectious Diseases
There is no known cause for this rare immune disorder and no evidence of person-to-person transmissivity
Do Lymph Nodes Enhance the Success of Immunotherapy?
University of California - San Francisco
New data show leaving lymph nodes intact until after immunotherapy could boost treatment efficacy